Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) для Age-Related Cognitive Decline

A

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Итог

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None или: None Outcome: Neurological health outcomes Эффект: None None

Популяция: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d или: None Outcome: Cognitive decline in AD Эффект: None None

Популяция: Alzheimer's disease patients

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None или: None Outcome: Age-dependent brain lipid changes Эффект: None None

Популяция: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Key Statistics

58

Исследования

12000

Участники

Positive

A

Оценка

Referenced Papers

Nutrients 2025 22 цитирований
Molecules (Basel, Switzerland) 2025 10 цитирований
Journal of proteome … 2025 8 цитирований
Journal of Alzheimer's … 2025 3 цитирований
Nutrients 2025 2 цитирований
Handbook of experimental … 2025 1 цитирований
Asia Pacific journal … 2025 1 цитирований
Arteriosclerosis, thrombosis, and … 2024 12 цитирований
Neuropsychopharmacology reports 2024 12 цитирований
Current opinion in … 2023 58 цитирований
Alzheimer's & dementia … 2023 7 цитирований
Nutrients 2022 76 цитирований
International journal of … 2022 39 цитирований
International journal of … 2022 23 цитирований
Biomolecules 2021 161 цитирований
Journal of alternative … 2021 13 цитирований
Current nutrition reports 2019 310 цитирований
Nutricion hospitalaria 2019 40 цитирований
American family physician 2018 101 цитирований
Pharmacological research 2018 67 цитирований
Nutricion hospitalaria 2018 32 цитирований
Frontiers in psychology 2018 13 цитирований
Advances in nutrition … 2017 215 цитирований
The Annals of … 2017 73 цитирований
Annals of the … 2016 89 цитирований
International journal of … 2014 23 цитирований
Nutricion hospitalaria 2014 17 цитирований
Advances in nutrition … 2013 155 цитирований
Neurobiology of aging 2011 91 цитирований
Current treatment options … 2011 6 цитирований
Molecular neurobiology 2010 145 цитирований
Women's health (London, … 2010 48 цитирований
JAMA 2010 3 цитирований
The Practitioner 2010
The Cochrane database … 2009 299 цитирований
Prostaglandins, leukotrienes, and … 2009 258 цитирований
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 цитирований
Prostaglandins, leukotrienes, and … 2006 176 цитирований
Medecine sciences : … 2005 19 цитирований
The Cochrane database … 2003 263 цитирований
Journal of Alzheimer's … 2003 161 цитирований
Pharmacological research 1999 1060 цитирований
Alternative medicine review … 1999 112 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Верхний предел: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --

Лучшее время приёма: With meals containing fat for better absorption

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Известные взаимодействия

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Допустимый верхний уровень потребления: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support Age-Related Cognitive Decline management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

Related Evidence

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.